Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) CEO Renee Gala sold 2,000 shares of the firm's stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $236.40, for a total transaction of $472,800.00. Following the completion of the transaction, the chief executive officer directly owned 141,394 shares in the company, valued at approximately $33,425,541.60. This represents a 1.39% decrease in their …